Category
Bortezomib
CAS Number
NA
Molecular Formula
C15H14N4O3
Molecular Weight
298.3 g/mol
Synonym

N-[(2S)-1-formamido-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide; (S)-N-(1-Formamido-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide; Pyrazine-2-carboxamide, (S)-N-(1-formamido-1-oxo-3-phenylpropan-2-yl);Bortezomib N-formyl Analog (USP); Bortezomib Related Compound E

Keywords
Intermediates
Pharmaceutical Standards
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib N-formyl analog is a chemical derivative of Bortezomib in which the amino group is converted into a formyl group. This structural modification can occur as a degradation product or during chemical synthesis and may alter the drug’s biological activity, stability, or proteasome-binding properties. Such analogs are monitored as impurities to ensure the safety and efficacy of bortezomib formulations.